COVID-19 Infection and Epithelial Cell Markers
NCT04787588 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 235
Last updated 2021-03-08
Summary
To assess if TSLP expression by airway epithelial cells following COVID-19 infection regulates viral load and disease severity.
Conditions
- Asthma
- Covid19
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gail Gauvreau, PhD · McMaster University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-14
- Primary Completion
- 2021-12-01
- Completion
- 2022-02-01
Countries
- Canada
Study Locations
More Related Trials
-
Effects of Neutrophil Extracellular Traps and Damage-associated Molecular Pattern Molecules on Long Term Use of Macrolides in Adults With Chronic Respiratory Disease
NCT05575726 ·Status: UNKNOWN
-
Microbial and Cytokine Signatures in Long COVID Patients
NCT07074158 ·Status: ENROLLING_BY_INVITATION
-
Respiratory Virus Metagenomics After COVID-19
NCT05126589 ·Status: RECRUITING
-
An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test
NCT04497675 ·Status: COMPLETED
-
Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections
NCT01779570 ·Status: COMPLETED ·Phase: PHASE4
-
Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia
NCT04469114 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
NCT05087199 ·Status: UNKNOWN
-
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
NCT06902194 ·Status: RECRUITING
-
Treatment of Nosocomial COVID-19
NCT04748588 ·Status: TERMINATED ·Phase: PHASE4
-
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
NCT01907659 ·Status: COMPLETED ·Phase: NA
-
Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2
NCT03012217 ·Status: COMPLETED
-
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510 ·Status: COMPLETED
-
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
NCT04887623 ·Status: RECRUITING
-
A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19
NCT04864535 ·Status: UNKNOWN
-
Home Testing of Respiratory Illness
NCT04245800 ·Status: COMPLETED
-
SARS CoV-2 Infection and Inflammatory Biomarkers
NCT05145751 ·Status: COMPLETED
-
The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study
NCT04868864 ·Status: UNKNOWN
-
Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic Use
NCT04171128 ·Status: COMPLETED
-
Respiratory Aerosols in Patients With COVID-19 and Healthy Controls
NCT04739020 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218 ·Status: COMPLETED
-
Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
NCT04358419 ·Status: COMPLETED
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN
-
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495 ·Status: UNKNOWN
-
Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study
NCT04903834 ·Status: UNKNOWN
-
Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings
NCT07217639 ·Status: NOT_YET_RECRUITING ·Phase: NA